A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study

[1]  Xian Guo,et al.  The Effects of Probiotics/Synbiotics on Glucose and Lipid Metabolism in Women with Gestational Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials , 2023, Nutrients.

[2]  M. Malibary.  Vitamin A: A Key Inhibitor of Adipocyte Differentiation , 2023, PPAR research.

[3]  Cheng Wang,et al.  Obesity and risk of gestational diabetes mellitus: A two-sample Mendelian randomization study. , 2023, Diabetes research and clinical practice.

[4]  R. Khan,et al.  Diagnostic Biomarkers for Gestational Diabetes Mellitus Using Spectroscopy Techniques: A Systematic Review , 2023, Diseases.

[5]  N. Moradi,et al.  Circulating Levels of C1q/TNF-Related Protein 3 (CTRP3) and CTRP9 in Gestational Diabetes and Their Association with Insulin Resistance and Inflammatory Cytokines. , 2022, Laboratory medicine.

[6]  A. Morisset,et al.  Trimester-Specific Serum Fructosamine in Association with Abdominal Adiposity, Insulin Resistance, and Inflammation in Healthy Pregnant Individuals , 2022, Nutrients.

[7]  Q. Lu,et al.  The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus , 2022, Journal of diabetes investigation.

[8]  E. Morales-Ávila,et al.  New Insights into Adipokines in Gestational Diabetes Mellitus , 2022, International journal of molecular sciences.

[9]  V. Schiffer,et al.  Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus , 2022, Nutrients.

[10]  G. Palma,et al.  Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes , 2022, International journal of molecular sciences.

[11]  I. Ceaușu,et al.  SERUM LEVELS OF ADIPONECTINE AND LEPTIN IN GESTATIONAL DIABETES MELLITUS - REVIEW , 2022, Research and Science Today.

[12]  Jun-Li Liu,et al.  Metabolic Effects of CCN5/WISP2 Gene Deficiency and Transgenic Overexpression in Mice , 2021, International journal of molecular sciences.

[13]  M. Hernández-Valencia,et al.  Maternal serum adipokines and inflammatory markers at late gestation and newborn weight in mothers with and without gestational diabetes mellitus. , 2021, Ginekologia polska.

[14]  A. Hou,et al.  High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway. , 2021, American journal of physiology. Endocrinology and metabolism.

[15]  D. Schwarz,et al.  Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[16]  P. Mozdziak,et al.  The Role of the Adipokines in the Most Common Gestational Complications , 2020, International journal of molecular sciences.

[17]  Gowri Dorairajan,et al.  Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth. , 2020, Placenta.

[18]  D. Piston,et al.  Insulin-Independent Reversal of Type-1 Diabetes Following Transplantation of Adult Brown Adipose Tissue Supplemented With IGF-1 , 2019, Transplantation direct.

[19]  Zu-hua Gao,et al.  Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival in vitro , 2019, Growth factors.

[20]  S. Del Prato,et al.  The role of adipokines in the pathogenesis of gestational diabetes mellitus , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[21]  D. H. Kim,et al.  CCN5 knockout mice exhibit lipotoxic cardiomyopathy with mild obesity and diabetes , 2018, PloS one.

[22]  P. Baker,et al.  The Pathophysiology of Gestational Diabetes Mellitus , 2018, International journal of molecular sciences.

[23]  S. Gogg,et al.  Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. , 2018, Physiological reviews.

[24]  Jie Ren,et al.  Characterization of Wnt1-inducible Signaling Pathway Protein-1 in Obese Children and Adolescents , 2018, Current Medical Science.

[25]  H. Boeing,et al.  Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity , 2018, Journal of Cell Communication and Signaling.

[26]  S. Twigg.  Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes , 2018, Journal of Cell Communication and Signaling.

[27]  U. Smith,et al.  CCN5/WISP2 and metabolic diseases , 2017, Journal of Cell Communication and Signaling.

[28]  F. Bäckhed,et al.  Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance , 2017, Scientific Reports.

[29]  A. J. van der Lely,et al.  The potential role of biomarkers in predicting gestational diabetes , 2016, Endocrine connections.

[30]  Masaharu,et al.  Seventh international workshop on the CCN family of genes , 2014, Journal of Cell Communication and Signaling.

[31]  G. Ning,et al.  IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin. , 2014, Endocrinology.

[32]  M. Laakso,et al.  WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4 , 2013, Proceedings of the National Academy of Sciences.

[33]  P. Arner,et al.  Functional annotation of the human fat cell secretome , 2012, Archives of physiology and biochemistry.

[34]  M. Mendall,et al.  Systematic review: adipose tissue, obesity and gastrointestinal diseases , 2006, Alimentary pharmacology & therapeutics.

[35]  B. Zinman,et al.  Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. , 2004, Diabetes care.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..